Ali Ünal

12PUBLICATIONS
85CO-AUTHORS
Haematological tumoursHaematologyInfant and child healthPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
Is CMV PCR Monitoring Necessary in Patients with Hematological Malignancy Receiving Chemotherapy? A Prospective Single-Center Study

|May 19, 2025
The efficacy and safety of therapeutic thrombocytapheresis in patients with extreme thrombocytosis.

Serhat Çelik, Zeynep Tuğba Güven, Muzaffer Keklik

|Apr 16, 2024
Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP.

Jacek Wachowiak, Jacques-Emmanuel Galimard, Arnaud Dalissier

|Feb 25, 2024
Determination of Risk Factors for Infectious Diarrhea in Patients with Hematological Malignancy.

Şükran Şahinkaya, Zeynep Ture, Ali Unal

|Apr 06, 2023
Risk factors for early onset acute kidney injury after allogeneic haematopoietic stem cell transplantation and the role of drug-drug interactions.

Ayşe Günay, Ali Ünal, Eren Demirpolat

|Sep 14, 2022
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia.

Guray Saydam, Ali Unal, Ibrahim Celalettin Haznedaroglu

Pageof 2

Frequent Collaborators

4 joint publications

Leylagül Kaynar

4 joint publications

Muzaffer Keklik

3 joint publications

İbrahim Celalettin Haznedaroğlu

3 joint publications

Zeynep Tuğba Karabulut